cancer, 85
breast, 74
ovarian, 36
disease, 26
ovarian cancer, 26
deficiency, 21
and, 19
breast cancer, 17
VHL, 16
syndrome, 15
cell, 14
C9, 12
renal, 11
BRCA1, 10
carcinomas, 10
of, 10
tumors, 9
C7, 9
G6PD, 9
sporadic, 9
DM, 9
WASP, 8
cancers, 8
C2, 8
pancreatic, 7
von, 7
dystrophy, 7
carcinoma, 7
familial, 7
bone, 6
Prostate, 6
Duarte, 6
RB1, 6
type, 6
HPRT, 6
hereditary, 6
dysplasia, 6
WAS, 6
ATM, 6
tumor, 6
hereditary breast, 6
mutations, 5
collagen, 5
Wiskott-Aldrich, 5
WT1, 5
Canavan, 5
galactosemia, 5
Classical, 5
C6, 5
von Hippel-Lindau, 5
III, 5
Hippel-Lindau, 5
Atm, 5
CHD, 5
papillary, 4
HPT, 4
tumour, 4
eye, 4
PAX3, 4
breast and ovarian cancer, 4
tumours, 4
Myotonic, 4
polymorphism, 4
PTEN, 4
adenocarcinoma, 4
IDDM2, 4
vWF, 4
5-HTT, 4
kidney, 3
breast / ovarian cancer, 3
human, 3
the, 3
Huntington, 3
inherited, 3
pancreatic tumors, 3
renal cell carcinomas, 3
complement, 3
JT, 3
Addisons, 3
renal hamartomas, 3
renal cell carcinoma, 3
variant, 3
solid, 3
Lesch-Nyhan, 3
APRT, 3
huntingtin, 3
Santamaria, 3
AT, 3
endometrial, 3
breast / ovarian, 3
insufficiency, 3
non-papillary, 3
breast and, 3
colorectal cancers, 3
breast cancers, 2
HPT-JT, 2
LA, 2
Ehlers-Danlos syndrome, 2
type IV Ehlers-Danlos, 2
variant of galactosemia, 2
IDDM, 2
IID von Willebrand disease, 2
autoimmune, 2
mutation, 2
lymphomas, 2
Small, 2
thrombocytopenia, 2
adrenocortical, 2
von Hippel-Lindau disease, 2
IV, 2
class, 2
coli, 2
aniridia, 2
C9 deficiency, 2
human breast cancer, 2
ALD, 2
retinoblastoma, 2
alveolar, 2
Ehlers-Danlos, 2
rhabdomyosarcoma, 2
heart, 2
bilateral, 2
Small eye, 2
adult, 2
adenomatous, 2
locus, 2
idiopathic, 2
paraplegia, 2
PMD, 2
Willebrand, 2
IID, 2
polyposis, 2
Adrenal, 2
X-linked, 2
prostatic, 2
terminal, 2
chromophobe, 2
colorectal cancer, 2
Wilms, 2
myotonic, 2
myotonia, 2
von Willebrand disease, 2
I, 2
SJS, 2
components, 2
colorectal, 2
disease-associated, 2
Li-Fraumeni, 2
von Willebrand, 2
sporadic breast and ovarian, 1
first, 1
breast carcinomas, 1
lipomas, 1
PLP-associated, 1
mismatched, 1
nonspherocytic hemolytic anemia, 1
tumorigenesis, 1
Denys-Drash, 1
attenuated, 1
infections, 1
recurrent, 1
Norrie disease ( ND, 1
spastic, 1
G6PD deficient, 1
deficiency of C9, 1
young onset breast cancer and ovarian cancer, 1
HPRT-deficient, 1
infertile, 1
tumorigenic, 1
leukocyte, 1
breast-ovarian, 1
nonpolyposis colorectal cancer ( HNPCC, 1
renal cell tumours, 1
heterozygous, 1
A-T, 1
Krabbe, 1
fatal, 1
Prader-Willi, 1
congenita, 1
red-blood-cell, 1
desmoplastic, 1
RCC, 1
childhood, 1
chondrodysplasias, 1
spinal, 1
primary, 1
caused, 1
related, 1
dehydrogenase, 1
fever, 1
X-linked spastic paraplegia, 1
retinal, 1
pancreatic cancer, 1
phosphoribosyl-transferase ( HPRT ) deficiency, 1
Alu, 1
Myotonic dystrophy ( DM, 1
breast and ovarian, 1
attack, 1
haploinsufficiency, 1
heritable, 1
desmoplastic small round cell tumour, 1
skeletal myopathy, 1
Mediterranean, 1
Mediterranean fever, 1
growth-retarded, 1
deficiency of C6 and C7, 1
dementia, 1
GALT, 1
Familial, 1
male, 1
fibre-type dependent atrophy, 1
leukemia, 1
oncogenic, 1
mental retardation, 1
glioblastomas, 1
short, 1
Pelizaeus-Merzbacher disease, 1
AKU, 1
COL2A1 splice site mutations, 1
diabetes, 1
anemia, 1
hemolytic, 1
small, 1
Prader-Willi syndrome ( PWS, 1
mesothelioma, 1
kidney allografts, 1
alveolar rhabdomyosarcoma, 1
DTD, 1
dominant, 1
haplotypes, 1
classic Li-Fraumeni syndrome, 1
Emery-Dreifuss, 1
dystrophia, 1
pediatric, 1
gene, 1
fibrillogenesis, 1
breast and ovarian cancers, 1
hereditary adult neuromuscular disease, 1
tumourigenesis, 1
Wiskott-Aldrich syndrome protein, 1
prostate, 1
early-onset breast and / or ovarian cancer, 1
phosphoribosyl-transferase, 1
onset, 1
personality disorders, 1
SPG, 1
X-Linked, 1
disease ( HD, 1
lymphoreticular, 1
hypoxanthine-guanine, 1
Pelizaeus-Merzbacher, 1
bilateral retinoblastoma, 1
aortic rupture, 1
breast cancer and ovarian cancer, 1
polymorphisms, 1
cerebellar, 1
sporadic aniridia, 1
muscular, 1
mellitus, 1
cardiomyopathy, 1
globoid cell leukodystrophy, 1
oncocytomas, 1
neuromuscular, 1
juvenile granulosa cell tumour, 1
severe, 1
haemangioblastomas, 1
breast or ovarian cancer, 1
membrane, 1
lymphoreticular disease, 1
retinoblastoma gene, 1
acute, 1
parenchymal, 1
Complement, 1
leukodystrophy, 1
AO, 1
atelosteogenesis type 2 ( AO2, 1
defective, 1
Hippel-Lindau tumor, 1
breast and / or ovarian cancer, 1
glucose-6-phosphate, 1
lymphoproliferative, 1
acetylcholine, 1
manifestations, 1
diastrophic dysplasia ( DTD, 1
Norrie, 1
breast / ovarian tumorigenesis, 1
acute myeloid leukemia, 1
spastic paraplegia, 1
CETP, 1
iris, 1
myeloid, 1
estrogen receptor-positive, 1
globoid, 1
tumour of the proband, 1
by, 1
round, 1
ovarian cancers, 1
hypoxanthine-guanine phosphoribosyl-transferase, 1
non-asbestos, 1
Neisseria, 1
renal cell carcinoma and phaeochromocytoma, 1
nonspherocytic, 1
hypoplasia, 1
parenchymal tumours, 1
exon-intron, 1
Denys-Drash syndrome, 1
nonpolyposis, 1
Meiosis, 1
meningitidis, 1
premature protein termination, 1
anxiety, 1
WT, 1
clear-cell, 1
Pediatric, 1
hypertrophic, 1
neisseria, 1
allografts, 1
T, 1
familial breast and ovarian, 1
chronic, 1
somatic-cell mosaicism, 1
fish-eye, 1
myotonica, 1
complex, 1
junctions, 1
neuronal, 1
Complete, 1
human breast carcinomas, 1
nicotinic, 1
coronary, 1
pancreatic cancers, 1
1, 1
hyperparathyroidism-jaw tumor syndrome, 1
kinases, 1
Autosomal, 1
prostate adenocarcinoma, 1
thymic, 1
enzyme deficiency, 1
Escherichia coli, 1
synergistic, 1
diabetes mellitus, 1
enzyme, 1
human tumours, 1
Aspergillus, 1
adrenoleukodystrophy, 1
cell-mediated, 1
meiotic failure, 1
breast and / or ovarian, 1
hypoxanthine-guanine phosphoribosyl-transferase ( HPRT ) deficiency, 1
